Partners' Committee. Each of Fox/Liberty Partner and Rainbow ------------------- Partner shall designate two individuals to serve on a committee (the "Partners' Committee") which shall be responsible for taking all action required under this Agreement to be taken by the Partners' Committee. Irrespective of the number of representatives attending any meeting of the Partners' Committee, each of Fox/Liberty Partner and Rainbow Partner shall have the right to one vote at such meetings (except as otherwise provided below and in Section 3.2 hereof with respect to a Forfeited Partner), such vote to be exercised in such manner as such Partner shall direct. The Partners' Committee shall meet by telephone or, at the request of any Partner, in person, not less frequently than (i) quarterly to receive the report of the Managing Partner contemplated by Section 4.1 and to review development plans, the financial position of the Partnership, the status of negotiations for the purchase and sale of programming rights, financial projections, and any other material matters relating to the business of the Partnership, (ii) annually to review the annual Budget and the Business Plan, and (iii) as often as shall be necessary to take any other action required to be taken or approved by the Partners' Committee. Any action that may be taken at a meeting of the Partners' Committee may be taken without a meeting by written consent of the number of Partners needed to authorize the action; provided, that -------- all Partners, regardless of whether all Partners are entitled to vote, are given notice of such written consent at least 15 Business Days prior to its effective date. Except as otherwise provided herein, any action required or permitted to be taken by the Partners' Committee must be by the approving vote of Partners entitled to vote and having Sharing Percentages aggregating at least 66 2/3% of the Sharing Percentages of all Partners entitled to vote; provided, that, if the -------- Managing Partner has been removed pursuant to Section 4.10, until a new Managing Partner shall have been appointed in accordance with Section 4.10, any action required or permitted to be taken by the Partners' Committee must be by the approving vote of each Partner entitled to vote. Any member of the Partners' Committee may be removed without cause and replaced at any time by the Partner who designated such member. If at any time a Partner removes one or both of its representatives on the Partners' Committee or any repr...

Partners' Committee. 8.1 The partners’ meeting shall, by resolution, set up a partners’ committee composed of six (6) members and lay down rules of procedure for such partners’ committee. The partners’ meeting shall appoint two (2) members nominated by Leipziger Messe GmbH and one (1) member nominated each by M+W, by the General Partner, by Fab 36 Admin and by Fab 36 Holding. Para. 7.7 shall apply mutatis mutandis to the adoption of resolutions by the partners’ committee. The members of the partners’ committee shall have as many votes as the Partners on the proposal of which they have been appointed (confer para. 7.7 sentence 4 and sentence 5).

Partners' Committee. (a) The "PARTNERS COMMITTEE", as of any time, shall consist of the members of the Board of Directors of Bermudaco who are also employees of the Company that hold the "Partner" title (or a title of similar dignity) and who agree to serve as members of the Partners Committee. If there are fewer than three individuals who are both Partners and members of the Board of Directors of Bermudaco, then such directors shall select such executive officers of Bermudaco that are Partners as they shall choose to serve as members of the Partners Committee to ensure that there at least three members of the Partners Committee. If there are no individuals who are both Partners and members of the Bermudaco Board of Directors, then the chief executive officer of Bermudaco shall serve as a member of the Partners Committee together with such other executive officers of Bermudaco that are Partners as he shall choose. Any member of the Partners Committee that is not a Covered Person hereunder shall be deemed to be a party hereto solely in his capacity as a member of the Partners Committee.

Partners' Committee. 34 4.3 Extraordinary Decisions...................... 36 4.4 Budget and Business Plan Approval............ 37 4.5

Partners' Committee. (a) The "PARTNERS COMMITTEE", as of any time, shall consist of the members of the Board of Directors who are also Partners of the Company and who agree to serve as members of the Partners Committee. If there are fewer than three individuals who are both Partners and members of the Board of Directors, then such directors shall select such Bermudaco executive officers that are Partners as they shall choose to serve as members of the Partners Committee to ensure there are at least three members of the Partners Committee. If there are no individuals who are both Partners and members of the Board of Directors, then the chief executive officer of Bermudaco shall serve as a member of the Partners Committee together with such other executive officers of Bermudaco that are Partners as he shall choose. The members of the Partners Committee from time to time will be party to this Agreement in their capacities both as Covered Persons and as Partners Committee.

Related to Partners' Committee

Operating Committee the Consortium’s managing body, composed of representatives of the Manager and the Contractors, pursuant to Annex XI.
Management Committee The Members shall act collectively through meetings as a "committee of the whole," which is hereby named the "Management Committee." The Management Committee shall conduct its affairs in accordance with the following provisions and the other provisions of this Agreement:
Advisory Committee The Settling State shall designate an Opioid Settlement Remediation Advisory Committee (the “Advisory Committee”) to provide input and recommendations regarding remediation spending from that Settling State’s Abatement Accounts Fund. A Settling State may elect to use an existing advisory committee or similar entity (created outside of a State-Subdivision Agreement or Allocation Statute); provided, however, the Advisory Committee or similar entity shall meet the following requirements:
Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).
Nominating Committee Subject to the provisions of Article X, the Nominating Committee shall consist of such number of Directors (none of whom shall be an employee of the Corporation) as may be determined from time to time by the Board. Subject to the provisions of Article X, the Committee shall review the qualifications of potential candidates for the Equity Directors and shall propose nominees for the Equity Directors who are nominated by the Board. Subject to the provisions of Article X, in making their nominations, the Nominating Committee and the Board of Directors shall take into consideration that (i) the Board of Directors shall have meaningful representation of a diversity of interests, including floor brokers, floor traders, futures commission merchants, producers, consumers, processors, distributors and merchandisers of commodities traded on Chicago Mercantile Exchange Inc. (the “Exchange”) or Board of Trade of the City of Chicago, Inc. (the “CBOT”), participants in a variety of pits or principal groups of commodities traded on the Exchange or the CBOT and other market users or participants; (ii) at least 10% of the members of Board of Directors shall be composed of persons representing farmers, producers, merchants or exporters of principal commodities traded on the Exchange or the CBOT; and (iii) at least 20% of the members of the Board of Directors shall be composed of persons who do not possess trading privileges on either the Exchange or the CBOT, are not salaried employees of the Corporation and are not officers, principals or employees who are involved in operating the futures exchange related business of a firm entitled to members’ rates on either the Exchange or the CBOT. Notwithstanding the foregoing, the Nominating Committee shall include the Chief Executive Officer of the Corporation as a nominee for an Equity Director at any annual meeting of shareholders at which his or her term is scheduled to expire; provided, that if such term expiration occurs during the Transition Period, the Chief Executive Officer shall be nominated as a CME Director. Subject to the provisions of Article X, a majority of the Nominating Committee shall constitute a quorum necessary to transact business.
Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.
Transition Committee 8.1.0 A transition committee comprised of the employee representatives and the employer representatives, including the Crown, will be established by January 31, 2016 to address all matters that may arise in the creation of the Trust.
Joint Steering Committee [***] following the Effective Date [***], a joint steering committee (the “JSC”) will be established by the Parties to provide oversight and to facilitate information sharing between the Parties with respect to the activities under this Agreement.
Executive Committee (A) The Executive Committee shall be composed of not more than nine members who shall be selected by the Board of Directors from its own members and who shall hold office during the pleasure of the Board.
Research Committee 2.2.1 Establishment and Functions of RC. ---------------------------------

Partners' Committee Sample Clauses

Filter & Search

Related Clauses

Parent Clauses

Related to Partners' Committee